Build your portfolio of top-class funds today.
Start systematic investing now!
Stocks - Q : Quality | V : Valuation | PT : Price Trend
Funds - P : Performance | Q : Quality
Funds - P : Performance | Q : Quality
Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :
| 1 Year | 3 Year | 5 Year | 9 Year | |
| CAGR(%) | 53.34 | 18.42 | 24.42 | N/A |
| Average Rolling Returns(%) | 27.74 | 16.37 | 25.74 | N/A |
The Current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan is ₹32.74.
It is better to invest in a fund with a longer track record as Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.92%
The process for redemption is
The AUM of Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan is currently ₹882 Crores.
The Top three stocks are Sun Pharma Inds., Cipla and Torrent Pharma and account for 30% of its portfolio. Top 5 and 10 stocks of fund account for 42% and 63% of fund’s portfolio respectively.
Top three sectors of Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan fund are Healthcare, Others and Miscellaneous accounting for 98% of the total portfolio.
Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.
Dhaval Shah manages the Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan Fund.
Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan current PE ratio is 46.12 and PB ratio is 7.79
The asset allocation of Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan is Stocks : 93.62%, Debt : 6.37% and Gold : 0%
The minimum SIP amount for Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹1000.00
The exit load for Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct Plan is 1% on or before 30 days, Nil after 30 days
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
